Ophthalmic Drugs Market to be Worth $65.6 Billion by 2030: Million Insights
Key Industry Insights & Findings from the report:Based on drug class insights, the anti-VEGF segment dominated the market with the largest revenue share of 31.5% in 2021 owing to rising demand and the adoption of anti-VEGF agents along with the rise in leading companies.Based on disease insights, the retinal disorder segment upheld the market with a 34.8% revenue share in 2021 due to a huge surge in diabetic retinopathy, macular degeneration, and fund for the expansion of treatment.Based on dosage form insights, the eye drops segment dominated the market with the largest revenue share of 39.3% in 2021 because of the accessibility of eye drops to overcome eye disorders with the implementation of novel technology.Based on product type insights, the prescription drugs segment upheld the market with the largest revenue share of 59.1% in 2021 owing to the provision of efficacy and safety with the usage of prescription drugs to combat disorders.Based on the route of administration insights, the topical route of administration dominated the market in 2021 and is expected to expand in the forecast period due to convenience dosage, patient compliance factors, and organizational strategies.Based on regional insights, North America dominated the market with a 39.3% revenue share in 2021 owing to rising awareness of eye disorders through R&D.
Read 150 page full market research report for more Insights, "Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Disease, By Dosage Form, By Route of Administration, By Product Type, By Region And Segment Forecasts From 2022 To 2030", published by Million Insights.
Ophthalmic Drugs Market Growth & Trends
According to the World Health Organization report of October 2021, 2.2 billion patients suffered from visual impairment out of which 1 billion cases can be diagnosed with the use of ophthalmic drugs. The COVID-19 outbreak severely impacted the market since a decline was observed in terms of clinical visits, visual check-ups, surgical procedures, and medications by 92.52%, 93.84%, 72.74%, and 19.63%. Owing to lockdown restrictions by governments globally, a reduction in clinical visits by patients affected with glaucoma negatively impacted market growth. But, owing to the increase in demand for COVID-19 vaccines, the market recovered gradually.
The focus of key players on R&D activities to initiate the availability of a wide range of products such as contact lenses, cataracts, and glaucoma products is projected to up-scale the market during the forecast period. Additionally, the creation of a pipeline for the purpose of exploring ophthalmic drug trials is constituted to expand the market with the introduction of the latest drugs to combat diseases, thus projected to escalate the market in the forecast period.
Ophthalmic Drugs Market Segmentation
Million Insights has segmented the global ophthalmic drugs market based on drug class, disease, route of administration, dosage type, product type, and region:
Ophthalmic Drugs Market - Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
·AntiallergyAnti-inflammatoryNon-steroidal drugsSteroidal drugsAnti-VEGF AgentsAnti-glaucomaOthers
Ophthalmic Drugs Market - Disease Outlook (Revenue, USD Million, 2018 - 2030)Dry EyeGelsEye Solutions & SuspensionsCapsules & TabletsEye DropsOintmentsEye AllergyGelsEye Solutions & SuspensionsCapsules & TabletsEye DropsOintmentsGlaucomaGelsEye Solutions & SuspensionsCapsules & TabletsEye DropsOintmentsEye InfectionGelsEye Solutions & SuspensionsCapsules & TabletsEye DropsOintmentsRetinal DisordersRetinal Disorder Treatment Market, By Type,Macular DegenerationDiabetic RetinopathyRetinal Disorder Treatment Market, By Dosage Type,GelsEye Solutions & SuspensionsCapsules & TabletsEye DropsOintmentsUveitisGelsEye Solutions & SuspensionsCapsules & TabletsEye DropsOintmentsOthers
Ophthalmic Drugs Market - Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)GelsEye Solutions & SuspensionsCapsules and TabletsEye DropsOintments
Ophthalmic Drugs Market - Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)TopicalLocal OcularRetinal DisordersSubconjunctivalIntravitrealRetrobulbarIntracameralSystemic
Ophthalmic Drugs Market - Product Type Outlook (Revenue, USD Million, 2018 - 2030)Prescription DrugsOTC Drugs
Ophthalmic Drugs Market - Regional Outlook (Revenue, USD Million, 2018- 2030)North AmericaU.S.CanadaEuropeGermanyU.K.FranceItalySpainRussiaAsia PacificJapanChinaIndiaAustraliaSouth KoreaSingaporeLatin AmericaBrazilMexicoArgentinaMiddle East and Africa (MEA)South AfricaSaudi ArabiaUAE
List of Key Players in the Ophthalmic Drugs MarketPfizer Inc.AlconNovartis AGBausch Health Companies Inc.Merck & Co., IncRegeneron Pharmaceuticals IncAllergan (AbbVie Inc)Bayer AGGenentech, Inc. (F. Hoffmann-La Roche Ltd)NicoxCoherus Biosciences, Inc.
Check out more latest studies published by Million Insights:Omega 3 Market - The global omega-3 market is anticipated to be worth USD 3.82 billion by 2028. Factors likely to drive the industry's growth include a rise in the occurrence of cardiovascular diseases (CVDs), modifications in dietary habits, and the importance of immunity development. The addition of omega-3 ingredients to the diet tends to maintain brain and heart health, which strives to increase the demand for the product.Hospital Gowns Market - The global hospital gowns market is expected to be worth USD 12.8 billion by 2030 and reveal a CAGR of 12.88%. Primary factors likely to drive this growth include an enhancement in the number of surgeries and a rise in the cases of healthcare-associated infections (HAIs) owing to poor sanitation and precaution. For instance, in 2020, according to a data report by HAIs, every year patients have been affected by infections at one in twenty-five hospitals.Wound Care Market - The global wound care market is expected to reach USD 29.6 billion by 2030, expanding at a CAGR of 4.1% during the forecast period from 2022 to 2030. The major factors positively influencing the growth of wound care include the rapid increase in the aging population, the growing number of surgical cases, and s, and the rise in the number of diabetic patients globally.Home Infusion Therapy Market - The global home infusion therapy market size is poised to reach USD 61.7 billion by 2030. The market is anticipated to expand at a CAGR of 7.9% from 2022 to 2030. The administration of medications at home through catheters and needles is referred to as home infusion therapy. Getting results at home without paying long bills to hospitals has gained people's attention.Viral Vectors And Plasmid DNA Manufacturing Market - The global viral vectors and plasmid DNA manufacturing market size is forecasted to reach USD 11.2 billion by 2030, registering a CAGR of 14.7% from 2022 to 2030. A viral vector is an apparatus used to deliver genetic material in cells. A virus has an exceptional mechanism to transport the DNA in the cells that they infect.Explore more Market Research Reports by Million Insights, for industry specific reports that provide real-time market trends and forecasts, by condensing the integral elements from our industry reports into bite-sized paragraphs, charts, and tables.
Access More Press Releases
About Million Insights:
Million Insights, is a market research and consulting company, provides syndicated as well as customized research reports and consulting services. We have a comprehensive marketplace, that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
Research Support Specialist, USA
Toll Free: 1-866-831-4085
Follow Us: LinkedIn | Twitter